Email This Article
Biopure Admits Its Blood Substitute Will Be Delayed
By
Adam Feuerstein
12/07/01 - 10:31 AM EST
The biotech won't meet a year-end deadline, saying Hemopure won't go to the FDA before mid-2002.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas